Skip to content

Clinical trials

Observational Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Observational Clear all

225 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20045
20052
20063
20074
200810
20092
20109
20119
201210
201310
201414
201511
20169
201711
20188
201917
202016
202111
202218
202314
202411
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108
Unknown status53
Recruiting32
Terminated9
Withdrawn8
Not yet recruiting6
Active, not recruiting5
Enrolling by invitation4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices11
JOTEC GmbH4
National Heart, Lung, and Blood Institute (NHLBI)4
National Institute of Neurological Disorders and Stroke (NINDS)4
Alvimedica3
Phenox GmbH3
University Hospital of Limerick3
Assistance Publique - Hôpitaux de Paris2
Bayer2
Cambridge University Hospitals NHS Foundation Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases225
Cardiovascular Diseases71
Heart Diseases41
Coronary Artery Disease37
Myocardial Ischemia31
Stroke31
Coronary Disease29
Cerebrovascular Disorders24
Arteriosclerosis23
Brain Diseases21

Trials

Showing 76 to 100 of 225. Each trial links to its page on Pharma Observatory.

125 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.